Pharmafile Logo
Pharmafocus logo
Advanced Search

ovarian cancer

Showing 15 posts of 55 posts found.

gsk_rd_harlow

GSK acquires oncology firm Tesaro for $5.1 billion

January 23, 2019
Research and Development Cancer, GSK, Tesaro, oncology, ovarian cancer

British multinational GlaxoSmithKline (GSK) have acquired US oncology firm Tesaro for $5.1 billion (£4 billion). Tesaro, a Massachusetts-based clinical stage …

News
astrazeneca_plaque

AstraZeneca scores hat trick in ovarian cancer and anaemia clinical trials

December 20, 2018
Research and Development AstraZeneca, anaemia, oncology, ovarian cancer, pharma

Anglo-Swedish multinational AstraZeneca has revealed that its ovarian cancer drug (Lynparza) and anaemia treatment (Roxadustat) have met their goals in …

News
shutterstock_159488225

Merck KGaA and Pfizer’s Bavencio falls short in ovarian cancer

November 20, 2018
Manufacturing and Production, Research and Development Bavencio, Cancer, Merck MGaA, Pfizer, ovarian cancer, pharma

Merck KGaA and Pfizer’s Bavencio (avelumab) has missed its primary endpoints in the treatment of platinum-resistant or -refractory ovarian cancer, …

News
astrazeneca_building_white

AstraZeneca’s Lynparza proves efficacy in first-line BRCA-mutated advanced ovarian cancer

June 27, 2018
Research and Development, Sales and Marketing AstraZeneca, Cancer, MSD, Merck, ovarian cancer, pharma

AstraZeneca is celebrating alongside partner MSD with the reveal of new data on the use of Lynparza in the first-line …

News
credit_-_daniel_leal-olivas-afp

European approval for tablet formulation of Lynparza in ovarian cancer

May 8, 2018
Research and Development, Sales and Marketing AstraZeneca, Cancer, EMA, Europe, MSD, lynparza, ovarian cancer, pharma

AstraZeneca and MSD’s poly ADP-ribose polymerase (PARP) inhibitor Lynparza (olaparib) has been approved for use in Europe, it has emerged, …

News
ovariancancer

Ovarian cancer rates set to rise by 55%

May 1, 2018
Manufacturing and Production, Medical Communications biotech, drugs, ovarian cancer, pharma, pharmaceutical

Ahead of World Ovarian Cancer Day on 8 May, new figures have been released suggesting that rates of this type …

News
shutterstock_274590824

J&J pays out $37m in damages over claims its talc contains asbestos

April 6, 2018
Medical Communications, Sales and Marketing Cancer, J&J, JJ, Johnson & Johnson, mesothelioma, ovarian cancer, pharma, talc

Bad news for Johnson & Johnson as it emerges that the US pharma giant has been ordered to pay out …

News

Patient experience: Living with ovarian cancer

April 3, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Ingrid Copperman, feature, ovarian cancer, patient experience, pharma

Ingrid Copperman recounts the many ways she has dealt with her diagnosis, as well as how the power of social …

Feature

FDA authorises first direct-to-consumer test for BRCA mutations, with caveats

March 6, 2018
Research and Development, Sales and Marketing 23andME, BRCA, Cancer, FDA, breast cancer, ovarian cancer, pharma

The FDA has given its authorisation to the first ever direct-to-consumer (DTC) test to identify three BRCA gene mutations which …

News
zappys_technology_solutions

Ovarian cancer risk may be inherited from the father, research indicates

February 16, 2018
Medical Communications, Research and Development Cancer, Roswell Park Comprehensive Cancer Centre, ovarian cancer

Researchers at the Roswell Park Comprehensive Cancer Centre in New York have published findings indicating that ovarian cancer risk may …

News
astrazeneca_sign_sky

AstraZeneca scores double approvals in Japan for asthma and ovarian cancer

January 19, 2018
Medical Communications, Sales and Marketing AstraZeneca, Cancer, Fasenra, Japan, asthma, lynparza, ovarian cancer, pharma

AstraZeneca has unveiled a double dose of approvals awarded to its medicines in Japan: Fasenra (benralizumab) has been given authorisation …

News
shutterstock_141299494

UK underperforming in cancer care compared to Europe, according to ABPI report

July 18, 2017
Research and Development ABPI, Cancer, Pancreatic cancer, biotech, heralthcare, lung cancer, ovarian cancer, pharma, pharmaceutical

According to a new report commissioned by the ABPI, the UK is continuing to fall behind in the diagnosis and …

News
ovarian_cancer

Breakthrough treatment for ovarian cancer displays promising results

June 5, 2017
Research and Development, Sales and Marketing Amgen, Cancer, ICR, ovarian cancer

A treatment that specifically targets ovarian cancer cells has shown that half of women who took the drug experienced shrinking …

News
shutterstock_95714119

Research identifies marker for aggressive ovarian cancer

April 26, 2017
Research and Development Cancer, ovarian cancer

Scientists have identified a marker which they believe can inform whether a tumour will become more aggressive and pose a …

News
shutterstock_38078521

Investigational ImmunoGen drug gives hope against platinum-resistant ovarian cancer

April 20, 2017
Research and Development Cancer, Immunogen, ovarian cancer

Research from GlobalData has suggested that an investigational drug from ImmunoGen could prove effective in treating platinum-resistant ovarian cancer, an …

News

Latest content

IDEAYA Biosciences announces first-patient-in for phase 1 clinical trial evaluating IDE397 and Trodelvy combination in MTAP-deletion bladder cancer

June 27, 2024

Immunotherapy created at Roswell Park Comprehensive Cancer Center given expanded ODD by FDA

June 27, 2024

Abcuro completes enrolment for phase 2/3 IBM treatment trial

June 26, 2024

AskBio initiates phase 2 Parkinson’s trial recruitment

June 26, 2024

AstraZeneca’s Tagrisso approved in Japan for lung cancer treatment

June 25, 2024